Form 4: Twist Bioscience Chief Accounting Officer Sells Shares for Tax Obligations
Insider Transaction Report
Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 242 shares of common stock for $29.747 per share to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp. (TWST), reported the sale of 242 shares of common stock.
- The transaction occurred on May 21, 2025, with shares sold at a price of $29.747 per share.
- This sale was a 'sell to cover' transaction, which is a non-discretionary sale mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
- Following this transaction, Mr. Werner beneficially owns 51,030 shares of Twist Bioscience common stock.
Sentiment
Score: 5
Explanation: The document reports a routine, non-discretionary 'sell to cover' transaction for tax purposes, which is a neutral event and does not indicate positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 05/08/2025 | Date Power of Attorney was executed by Robert Werner. |
| 05/21/2025 | Date of common stock transaction by Robert F. Werner. |
| 05/23/2025 | Date Form 4 was signed by Attorney-in-Fact for Robert F. Werner. |
Keywords
Twist Bioscience, TWST, SEC Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Chief Accounting Officer, Robert F. Werner, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.